Sponsor pipeline

Pharmicell Co., Ltd. clinical trial pipeline

Get alerts when Pharmicell Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 3
1
Not charted: 4 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT04689152 Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in… Alcoholic Cirrhosis Recruiting 2026-09-21
Not applicable
NCT07400458 Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration Acute Myocardial Infarction Recruiting 2026-02-10
Not specified
NCT05093881 Long-Term Follow-up of Patients With Alcoholic Liver Cirrhosis Treated With Cellgram-LC Alcoholic Liver Cirrhosis Recruiting 2026-09-21
NCT07431008 Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction Erectile Dysfunction Recruiting 2026-02-24
NCT05096182 Long-Term Follow-up of Patients With Chronic Kidney Disease Treated With Cellgram-CKD Chronic Kidney Disease Active, Not Recruiting 2026-09-25

Disease areas by active trials

Chronic Kidney Disease (1)

Get alerts when Pharmicell Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free